Reviticell is developing simple and effective therapeutic systems—or kits— that are positioned to transform the regenerative medicine industry.The Reviticell Kit is a complete Protocol-in-a-Box for physicians—a “paint-by-numbers” system for safely and effectively preparing a patient’s own blood or body fat to unlock the healing powers within. Reviticell's Stem-Cell Therapy Kits are being developed to treat various diseases and conditions, such as Heart disease, Diabetes, Alzheimer’s, Leukemia, Lymphoma, Parkinson’s, just to name a few.
Each Reviticell Kit is customized for a specific regenerative medical procedure and comprised of essential components and solutions to make possible a variety of safe and effective regenerative medical therapies. In addition, Reviticell Kits will accelerate the research and development of new therapies. The impact of this revolutionary breakthrough goes deep and Reviticell is poised to be the industry standard for regenerative medicine therapies, an industry which is predicted to reach nearly $70 billion by 2019. Join the revolution in helping these advancements in medical science. Participate in this Reviticell opportunity and join the effort to make a difference in the quality of life for millions of people… to help provide real second chances, reach out today.. For complete details about this investment opportunity, contact us at:
Are there really second chances in life? Can science and medicine help provide us what we need to make a real impact in people’s lives? The answer is yes. We are at the forefront of a revolution in modern medicine that will forever change the way we treat, the way we heal… the way we restore lives!
Reviticell Holdings Inc. is offering the sale of its stock to “Accredited Investors” (as such term is defined in the Securities Act of 1933) in order to raise $4,000,000 to commercialize its revolutionary Reviticell Kits. You can participate in this exciting effort to enhance and extend patient lives at only $1.00 per share and a $10,000 minimum. And, for each four shares pruchased, you'll even receive a warrant to purchase stock in the future at $1.00 per share.
Reviticell’s management team has extensive experience in product and business development, marketing and sales, and managing successful fast-growth businesses in multiple markets in the US and abroad. Once funded, Reviticell will move forward with its plans to capitalize on the scalability of the Reviticell Kit system which is One System for Many Therapies.
Reviticell is positioned to become the industry standard because no other company is focused on the optimization and standardization of the process for safely and efficiently preparing a patient’s blood and/or body fat in order to leverage the innate restorative powers of the body. As such, revenue will rapidly increase with penetration into multiple markets and production of private-labeled kits for a variety of world-class industry leaders. Patent-pending Reviticell Kits comprise leading-edge technologies developed at world-class institutions and are configured with best-in-class components produced by industry leaders.
Revenue & Expense estimates for Reviticell model an investor “exit” between four and five years after funding. It is anticipated that such an exit would be in the form of a management buy-out; however it is also possible that such an exit could result from an Initial Public Offering or due to an acquisition of all or a part of the company.
Reviticell Kit, Corishape, Corishaping, Corase, names used for all Reviticell Kits, Protocol-in-a-Box and One System for Many Therapies are trademarks owned by Reviticell Holdings, Inc.
The foregoing information is not an offer to sell membership interests of Reviticell Holdings, Inc. Membership interests will not be offered until a Private Placement Memorandum and/or other such documents have been provided to a prospective investor.